TIAA CREF Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.64M | Buy |
227,358
+670
| +0.3% | +$4.85K | ﹤0.01% | 2096 |
|
|
2018
Q4 | $1.68M | Buy |
226,688
+2,009
| +0.9% | +$14.9K | ﹤0.01% | 2049 |
|
|
2018
Q3 | $1.22M | Sell |
224,679
-95,083
| -30% | -$515K | ﹤0.01% | 2354 |
|
|
2018
Q2 | $1.14M | Buy |
319,762
+71,920
| +29% | +$255K | ﹤0.01% | 2441 |
|
|
2018
Q1 | $508K | Buy |
247,842
+7,897
| +3% | +$16.2K | ﹤0.01% | 2725 |
|
|
2017
Q4 | $633K | Sell |
239,945
-10,806
| -4% | -$28.5K | ﹤0.01% | 2669 |
|
|
2017
Q3 | $1.32M | Buy |
250,751
+30,890
| +14% | +$162K | ﹤0.01% | 2387 |
|
|
2017
Q2 | $783K | Buy |
219,861
+9,062
| +4% | +$32.3K | ﹤0.01% | 2663 |
|
|
2017
Q1 | $1.09M | Sell |
210,799
-15,752
| -7% | -$81.5K | ﹤0.01% | 2471 |
|
|
2016
Q4 | $861K | Sell |
226,551
-8,234
| -4% | -$31.3K | ﹤0.01% | 2625 |
|
|
2016
Q3 | $2.1K | Sell |
234,785
-6,341
| -3% | -$57 | ﹤0.01% | 2146 |
|
|
2016
Q2 | $1.7M | Buy |
241,126
+31,766
| +15% | +$223K | ﹤0.01% | 2228 |
|
|
2016
Q1 | $1.78M | Buy |
209,360
+712
| +0.3% | +$6.05K | ﹤0.01% | 2141 |
|
|
2015
Q4 | $2.74M | Sell |
208,648
-8,495
| -4% | -$112K | ﹤0.01% | 1975 |
|
|
2015
Q3 | $795K | Hold |
217,143
| – | – | ﹤0.01% | 2708 |
|
|
2015
Q2 | $1.25M | Buy |
217,143
+13,260
| +7% | +$76.4K | ﹤0.01% | 2579 |
|
|
2015
Q1 | $1.19M | Sell |
203,883
-3,619
| -2% | -$21.1K | ﹤0.01% | 2522 |
|
|
2014
Q4 | $1.63M | Sell |
207,502
-30,640
| -13% | -$240K | ﹤0.01% | 2372 |
|
|
2014
Q3 | $1.17M | Sell |
238,142
-66,641
| -22% | -$327K | ﹤0.01% | 2546 |
|
|
2014
Q2 | $1.88M | Buy |
304,783
+72,620
| +31% | +$449K | ﹤0.01% | 2332 |
|
|
2014
Q1 | $1.24M | Sell |
232,163
-6,690
| -3% | -$35.8K | ﹤0.01% | 2519 |
|
|
2013
Q4 | $1.25M | Buy |
238,853
+24,300
| +11% | +$127K | ﹤0.01% | 2537 |
|
|
2013
Q3 | $1.19M | Buy |
214,553
+6,753
| +3% | +$37.3K | ﹤0.01% | 2517 |
|
|
2013
Q2 | $524K | Buy |
+207,800
| New | +$524K | ﹤0.01% | 2923 |
|